Skip to main content
DTIL logo

DTIL · Precision Biosciences Inc · Debt

Track DTIL — free
$6.55 +0.36 (+5.82%)
Market Cap
$170.85M
Shares
27.60M
Volume · Oct 20 210.91K Avg daily vol (3M) 262.79K

Debt Profile

Completed filing coverage through Oct 20, 2023

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Loans payable, including current maturities 2026-06-30 USD 22,421,000 10-Q filed 2026-08-06
Operating lease liabilities 2026-06-30 USD 5,680,000 10-Q filed 2026-08-06
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 1,608,000
Noncurrent operating lease liabilities
USD 4,072,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1357874 CUSIP 74019P207 13F (30d) 9 filings 9 filers Visit website Investor relations